A study from North America has proposed the combination of total tumor volume (TTV) <115 cm3 and AFP <400 ng/mL for the selection of HCC patients, showing that patients exceeding these cut-offs presented very poor post-LT results (below 50% at 3 years) [33]. This evidence concerns the gene AFP and hepatocellular carcinoma.